Desmopressin EP Impurity E arises from synthetic variation or minor degradation of desmopressin. Such structural changes influence disulfide topology, polarity, and chromatographic behavior. Researchers use it as a reference for impurity quantification. Applications include stability analysis, synthetic-route verification, and peptide-quality assessment.
CAT No: R2782
Synonyms/Alias:N5,4-[(Acetylamino)methyl]desmopressin;(S)-1-((4R,7S,10S,13S,16S)-10-(3-acetamido-3-oxopropyl)-7-(2-amino-2-oxoethyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((R)-1-((2-amino-2-oxoethyl)amino)-5-guanidino-1-oxopentan-2-yl)pyrrolidine-2-
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.